<DOC>
	<DOC>NCT00687388</DOC>
	<brief_summary>Non-steroidal Anti-inflammation Drugs can effectively reduce the lower urinary tract symptoms from benign prostatic hyperplasia</brief_summary>
	<brief_title>The Clinical Efficacy of Non-steroidal Anti-inflammation Drugs in Patients With Benign Prostatic Hyperplasia</brief_title>
	<detailed_description />
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Tamsulosin</mesh_term>
	<mesh_term>Doxazosin</mesh_term>
	<mesh_term>Terazosin</mesh_term>
	<mesh_term>Prazosin</mesh_term>
	<mesh_term>Alfuzosin</mesh_term>
	<mesh_term>Adrenergic alpha-Antagonists</mesh_term>
	<mesh_term>Anti-Inflammatory Agents, Non-Steroidal</mesh_term>
	<mesh_term>Celecoxib</mesh_term>
	<criteria>Who had the treatment of BPH with alpha1 blockers for more than 3 months Who have the IPSS(International Prostatic Symptom Score) &gt;= 15 Who have the maximum flow rate(Qmax) &lt; 15 with voided volume &gt; 150mL Who have the PPBC(patient's perception of bladder condition) &gt;= 3 (The PPBC was assessed by the use of a six point ordered categorical scale(16 point). The higher score means the higher bother) Who had the PSA level &lt; 4 ng/mL within 6 months (But, the patient who are revealed not to have prostate cancer by prostate biopsy can be included even if he had PSA level of 410 ng/mL) Who underwent the transrectal ultrasound of prostate within 6 months Who can understand this study and can give the informed consent Who had regular intake of 5alpha reductase inhibitor or NSAID within 6 months before screening Who have peptic ulcer and/or asthma Who have urologic malignancies such as prostate cancer and bladder cancer Who have urethral strictures, large bladder diverticuli, and bladder neck contractures Who had surgical treatment for BPH Who have histories of bladder and/or urethra Who have serum PSA level more than 10 ng/ml Who have histories of orthostatic hypotension Who have serum creatinine level more than 2.0 mg/dl Who have serum ALT and/or AST level more than 1.5 times of normal upper limit Who have heart failure Who have histories of bacterial prostatitis within 1 year Who have histories of active urinary tract infection within 1 month Who have histories of the biopsy of bladder and prostate within 1 month Who are unable to void Who use pads because of incontinences Who have hypersensitivities for alpha blockers that include quinazoline, NSAID, aspirin, sulfonamide Who have histories of unstable angina, myocardial infarction, and cerebrovascular accident within 6 months Who have neurogenic bladder due to multiple sclerosis, Parkinson's disease, Spinal injuries and etc. Who have thinking disturbances Who have histories of abuses of alcohol and/or other drugs Who seem to be not fit to this study by the decision of investigators</criteria>
	<gender>Male</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2013</verification_date>
	<keyword>Cyclooxygenase 2 Inhibitors</keyword>
	<keyword>Alpha Blockers</keyword>
	<keyword>Treatment Outcome</keyword>
</DOC>